OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)

OPTUS Pharmaceutical Revenue

In the year 2025, OPTUS Pharmaceutical had annual revenue of 87.16B KRW with 6.42% growth. OPTUS Pharmaceutical had revenue of 22.56B in the quarter ending December 31, 2025, a decrease of -1.81%.

• Revenue: 87.16B
• Revenue Growth: +6.42%
• P/S Ratio: 1.44
• Revenue / Employee: 548.18M
• Employees: n/a
• Market Cap: 125.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.16B	5.26B	6.42%
Dec 31, 2024	81.90B	9.48B	13.09%
Dec 31, 2023	72.43B	13.77B	23.47%
Dec 31, 2022	58.66B	1.34B	2.34%
Dec 31, 2021	57.32B	-3.51B	-5.77%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error